Erasca, Inc. (ERAS) Misses Q2 EPS by 11c

Erasca, Inc. (NASDAQ: ERAS) reported Q2 EPS of ($0.29), $0.11 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Erasca, Inc. (ERAS) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• TripAdvisor (TRIP) in the money January 13 puts active
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14